Newsletter | December 11, 2024

12.11.24 -- Optimizing Stability Storage: The Benefits Of Outsourcing

Two Steps Forward, One Step Back: IND Submission In Early Development

In a roundtable discussion, a panel of product development experts examined the blind spots that can plague an early development strategy, as well as which considerations must be accounted for when navigating the path toward an IND submission.

 

Costs And Risks Associated With In-House Stability Storage

By performing stability storage in-house, you are taking on several risks related to capital expenditures, operational expenditures, and compliance. Find out how you can save your resources and finances by eliminating stability storage risks.

 

Removing The Headache: Outsourced Stability Storage And Testing Solutions

In this webinar, Darryl Souness, Head of Analytical at Cambrex Edinburgh, and Stephen Delaney, Managing Director at Q1 Scientific (a Cambrex Company), share insights on the benefits of outsourcing stability storage and testing.

 

SOLUTIONS

Complex Synthetic Molecule Development, Manufacturing

See how our innovative capabilities and advanced technologies can optimize the development and manufacturing of complex synthetics for drug substances, medical devices, and diagnostic agents.

• Request Information

 

 

 

Visionary Thinkers, Problem Solvers: The Cambrex Team

Learn how the diverse backgrounds and fields of experience of the Cambrex team members help to provide you with the opportunity to change lives and seamlessly advance your molecule.

• Request Information